Background. Leprosy is characterized by a spectrum of clinical manifestations that depend on the type of immune response against the pathogen. Patients may undergo immunological changes known as "reactional states" (reversal reaction and erythema nodosum leprosum) that result in major clinical deterioration. The goal of the present study was to assess the effect of Toll-like receptor 2 (TLR2) polymorphisms on susceptibility to and clinical presentation of leprosy.
Leprosy is characterized by a polarized spectrum of clinical manifestations that correlate with the level of cellmediated immune response against Mycobacterium leprae [1, 2] . At one end, patients with tuberculoid leprosy manifest a strong cellular immune response with localized lesions that have few or no bacilli in well-formed granulomas with the expression of Th1 cytokines [2] [3] [4] .
At the opposite end, patients with lepromatous leprosy have a suboptimal cellular immune response, disseminated infection with extensive lesions characterized by the presence of numerous intracellular bacilli, and the expression of Th2 cytokines. Many patients with leprosy have an unstable response to the pathogen and may undergo immunological changes known as "reactional states," resulting in major clinical alterations. Reversal reaction represents a sudden shift of the immune system, often toward the tuberculoid pole, with an increased cell-mediated response against M. leprae antigens that can rapidly lead to severe tissue damage [5] . Reversal reactions are observed more frequently among patients with borderline lepromatous leprosy, especially after the initiation of multidrug therapy, with an incidence rate ranging from 18% to 44% [6] . Although genetic studies have implicated several genes in susceptibility to leprosy, the genetic factors that predispose individuals to reversal reaction remain unknown [2, [7] [8] [9] .
Toll-like receptors (TLRs) are type 1 transmembrane proteins expressed in innate immune cells that play a critical role in the inflammatory response to microbial pathogens [10, 11] . The extracellular domain comprises leucinerich repeat structures that can recognize a vast range of microbial products. On activation, the intracellular domain elicits a complex signal transduction that ultimately activates the transcription of proinflammatory cytokines. These cytokines play an essential role in the host innate immune response and determine the activation of adaptive immune mechanisms [12] . We previously demonstrated that TLR-2 mediates the innate immune recognition of M. leprae [13] . Polymorphisms in TLR2 have recently been found to be associated with susceptibility to several infectious diseases, including mycobacterial infections [14 -18] . In this study, we investigate whether TLR2 polymorphisms are associated with susceptibility to leprosy and/or leprosy reactions in a case-control study from Ethiopia. We demonstrate an association between TLR2 polymorphisms and reversal reaction among patients with leprosy.
PATIENTS, MATERIALS, AND METHODS
Case-control study. Patients with a history of leprosy were drawn from AMFES (All-Africa Leprosy Rehabilitation and Training Multidrug Therapy Field Evaluation Study), a longterm study of fixed-duration multidrug therapy in Ethiopian patients with leprosy [19] . Ethnicity was self-reported and comprised 3 major ethnic groups (Oromo, Amhara, and Gurage). Healthy control subjects from each ethnic group were recruited from the local population (n ϭ 197). The enrollment procedures and the administration of treatment have been described elsewhere [19, 20] . Briefly, patients were enrolled at one of the clinics in the study area between 1988 and 1993 and were followed for 5 to 11 years after release from treatment (n ϭ 441). Skin smears were done routinely, and the bacillary index and morphological index were recorded for each of 4 sites. Leprosy types were established on clinical grounds according to the simplified Ridley/Jopling classification, which adds the rarely occurring midborderline patients to the borderline lepromatous (BL) group [21] . A small number of patients were classified as multibacillary (MB) or paucibacillary (PB), according the World Health Organization classification (n ϭ 25). Leprosy reactions were reported only in a subgroup of patients (n ϭ 216). Reactions were diagnosed on the basis of clinical findings of signs of inflammation in leprosy skin lesions, which has been extensively described elsewhere [22, 23] . Although reversal reaction can occasionally occur for the first time Ͼ5 years after the start of treatment, the vast majority occur within the first year, as has been shown in previous studies [22, 23] . The patients who were assessed for leprosy reactions had been followed for at least 8 years, to insure that all nonreactional patients with leprosy were truly nonreactional. Subjects were informed of the risks and benefits of the study and signed a consent form. Genomic DNA was extracted from whole blood by use of the Nucleon DNA Extraction Kit (Amersham Biosciences). Approval for human study protocols was obtained from the human subject review boards at the Armauer Hansen Research Institute, Rockefeller University, the Public Health Research Institute, the University of Washington, and the Western Institutional Review Board.
TLR2 microsatellite. The TLR2 microsatellite marker is located between 162 and 100 bp upstream of the start codon of TLR2 and contains 2 subsequent variable nucleotide tandem repeats (VNTRs), CT and TG. We amplified a fragment of the genomic DNA from the patients with leprosy and the control subjects comprising these 2 VNTRs by use of the primers 5'-TCCGGATGGTTGTGCTTTTAAGTACTGC-3' and 5'-GTGGCATTGTCCAGTGCTTCAACC-3'. Samples were cycled using a Peltier Thermal Cycler (MJ Research). Polymerase chain reactions (PCRs) incorporated an infrared dye (IRD700-dATP; Enzo/LI-COR) and were analyzed on LI-COR 4200 automated sequencers (LI-COR Biosciences), as described elsewhere [24] . In-house genotyping software (SAGA; LI-COR Biosciences) was used to determine alleles. Calls were confirmed by manual checking. Analysis of a PCR product revealed 18 different allelic forms, with lengths ranging from 262 to 302 bp, corresponding to microsatellite lengths of 40 to 80 bp, respectively. The most frequent allelic lengths were 280 (33%), 282 (13%), 284 (13%), 288 (6%), and 290 (10%) bp, representing ϳ80% of the alleles. The microsatellite maker was in Hardy-Weinberg equilibrium among case patients and control subjects of the 3 ethnicities, excepted in Oromo case patients (P ϭ .03). Allelic lengths with frequencies Ͻ5% were grouped together.
Single-nucleotide polymorphisms (SNPs). Selection of SNPs for high throughput was performed using a public database of TLR SNPs (Innate Immunity Program in Genomic Applications database; available at: http://innateimmunity.net/) as well as SNPs reported in the literature [14, 25] at the time genotyping was started. SNPs in the coding region of TLR2 that induced amino acid change as well as synonymous SNPs with a frequency of Ͼ5% were selected for high-throughput genotyping in the whole population by use of Sequenom technology, as described elsewhere [26] . On the basis of these criteria, 4 SNPs were selected (597C3 T, N199N, rs3804099; 1350T3 C, S450S, rs3804100; 2029C3 T, R677W; and 2258G3 A, R753Q, rs5743708). However, only 2 synonymous SNPs were detected in the Ethiopian population (597C3 T and 1350T3 C); 597C3 T and 1350T3 C were in Hardy-Weinberg equilibrium among case patients and control subjects of the 3 ethnicities. The 2029C3 T SNP that had been associated with the occurrence of lepromatous leprosy in a Korean population was subsequently found not to be a true TLR2 polymorphism [25, 27] . In fact, the C3 T substitution is located in a pseudogene region highly homologous to the TLR2 exon 3, which is located ϳ23 kb upstream from the TLR2 gene [27] . Subsequent studies suggested that the 2258G3 A [R753Q] SNP that was associated with tuberculosis in Turkey is restricted to white populations [14, 28] .
Haplotypes. Haplotypes including the TLR2 microsatellite polymorphisms and the 597C3 T and 1350T3 C SNPs were inferred separately for each ethnic group by use of the expectation-maximization algorithm implemented in the DE-CIPHER program (S.A.G.E.) [29] . The most frequent haplotypes among all ethnic groups were 280-C-T (35%), 290-T-T (11%), 282-T-T (9%), 284-C-T (8%), 288-T-T (6%), and 284-T-T (5%), representing ϳ75% of all haplotypes. Haplotypes with frequencies Ͻ5% were grouped together.
Statistical analysis. All analysis were performed using Stata (version 9; StataCorp). The risk associated with TLR2 SNPs were assessed in general multivariate logistic regression models that did not assume any particular mode of inheritance and accounted for the presence of each genotype (0/1 and 1/1) versus the wild-type genotype (0/0; analysis by genotype). A similar method was used for multiallelic markers (microsatellite allelic lengths and haplotypes), but the reference (0/0) was the absence of marker (i.e., all patients who did not have a copy of the microsatellite allelic length or the haplotype). To assess associations of interest, we performed likelihood ratio tests for 3 different models (dominant, recessive, and additive) versus the general model. The best-fitting model was assumed in the final presentation of the results. All analyses were adjusted for age groups, sex, and ethnicity (when applicable). Because of the limited sample size, statistical analyses were initially performed in the whole population. Consistency of significant results was then verified within each ethnic group.
RESULTS
The general characteristics of the 441 case patients and 197 control subjects are shown in table 1. Both groups had similar male to female ratios. Mean age was significantly lower in control subjects than in case patients (mean Ϯ SD, 29.1 Ϯ 12.4 vs. 39.0 Ϯ 15.1 years; P Ͻ .001). A total of 298 case patients (68%) were grouped into the lepromatous pole, including 199 case patients classified as BL, 81 classified as lepromatous lepromatous (LL), and 18 classified as MB. Of the 138 case patients grouped into the tuberculoid pole, most were classified as borderline tuberculoid (BT; n ϭ 128). The remaining patients were classified as tuberculoid tuberculoid (TT; n ϭ 3) or PB (n ϭ 7).
Of the 441 patients, 216 had complete data on leprosy complications. Neuritis was the most common complication and occurred in 72% of BL patients, 69% of LL patients, and 49% of BT patients. Reversal reaction occurred almost exclusively among borderline patients (38% of BL patients, 28% of BT patients, and NOTE. Data are no. (%) of patients, unless otherwise indicated. P values are exact P values for the overall distribution of sex and age groups within the different ethnic groups and for the overall distribution of leprosy type and leprosy reactions among the 3 different ethnic groups. BL, borderline lepromatous; BT, borderline tuberculoid; ENL, erythema nodosum leprosum; LL, lepromatous lepromatous; TT, tuberculoid tuberculoid.
a Ethnicity was missing for 10 patients and 10 control subjects. Thus, totals in the last columns are slightly higher than the totals for case patients from the 3 ethnic groups.
b Age was missing for 28 patients and 3 control subjects. c Leprosy type was missing for 5 patients; 25 patients classified according World Health Organization criteria as multibacillary (MB; 18 case patients) or paucibacillary (PB; 7 case patients) are not shown. Therefore, a total of 298 patients were lepromatous (81 LL ϩ 199 BL ϩ 18 MB) and a total of 138 were tuberculoid (128 BT ϩ 3 TT ϩ 7 PB) (see 3% of LL patients), and erythema nodosum leprosum was, as expected, found exclusively among lepromatous patients (19% of LL patients and 10% of BL patients). The frequency of TLR2 polymorphisms was similar among the 3 ethnic groups (table 2) . Pairwise linkage disequilibrium between TLR2 SNPs and microsatellite allelic lengths are shown in table 3.
To investigate whether susceptibility to leprosy was associated with TLR2 polymorphisms, we compared frequencies of TLR2 polymorphisms among leprosy case patients in a general model, adjusting for sex, age groups, and ethnicity (table 4). There were no relevant differences in the frequencies of 597C3 T and 1350T3 C, but the 290-bp allelic length of the microsatellite marker was less frequent among leprosy case patients than control subjects ( We then investigated whether TLR2 polymorphisms were associated with leprosy reactions. Although no associations were found with neuritis or erythema nodosum leprosum (data not shown), reversal reaction was associated with the TLR2 597C3 T SNP and the microsatellite marker ( (table 7) . This association was consistent among the 3 ethnic groups, although the P value was not significant for the Gurage ethnicity because of reduced sample size (table 7) . Homozygosity for the 280-bp allelic length of the mi- (table 7) . This observation was consistent among the 3 ethnic groups, even though the sample size among Gurage subjects was limited.
To determine whether coinheritance of the 3 TLR2 microsatellite polymorphisms, 597C3 T and 1350T3 C, and the microsatellite further increased the risk of reversal reaction, we examined the association between TLR2 haplotypes and reversal reaction (table 8) . Homozygosity for a TLR2 haplotype contain- NOTE. Listed frequencies (%) are for the presence of 0 (0/0), 1 (0/1), or 2 (1/1) copies of the genotype or allelic length. P values were calculated using a logistic regression model including 0/1 and 1/1, with 0/0 as the reference (a general model that did not assume any particular type of inheritance was used), adjusted for age group, sex, and ethnicity. OR, odds ratio.
a Microsatellite indicates the size of the polymerase chain reaction (PCR) product. .07]; P Ͻ .001). Again, the association was consistent among the 3 ethnic groups, even though the sample size for Gurage patients was small (only 2 patients had the 280-C-T/280-C-T diplotype, and both had reversal reaction) (table 7) .
DISCUSSION
In the present article, we show a significant association between a TLR2 microsatellite polymorphism as well as a TLR2 SNP (597C3 T) and the occurrence of reversal reaction among patients with leprosy. The observation is strengthened by the fact that the biological role played by TLR-2 in leprosy has been previously established and that the observations are consistent among 3 different ethnic groups. Leprosy is characterized by a polarized immunological response ranging between the tuberculoid and the lepromatous poles, which vary in the level of cell-mediated immunity against M. leprae. Reactional states such as reversal reaction reflect dynamic changes in the immune response that provide insight into the immunopathogenesis of disease. Reversal reaction represents a shift of the cellular immune response, often from the Table 7 . Associations between TLR2 markers and reversal reaction (RR) in the different ethnic groups. lepromatous to the tuberculoid form, usually occurring after starting treatment. Reversal reaction lesions contain infiltrating T cells producing a Th1 pattern of cytokines that is characteristic of cell-mediated immunity and is associated with increased killing of M. leprae [5] . The factors that trigger changes in the cytokine patterns in leprosy lesions remain largely unknown. On ligand binding, Toll-like receptors mediate maturation of dendritic cells, leading to the secretion of cytokines that can direct the adaptive T cell response toward either a Th1 or a Th2 pattern [12] . Recently, TLR-2 has been shown to be essential for the recognition of M. leprae and to be expressed in tuberculoid lesions [13, 30] . These data suggest that TLR-2 may play a significant role in the changes in immune response that occur during reversal reaction. Although little information is available on the role played by host genetic polymorphisms in susceptibility to reversal reaction, previous studies have shown associations between susceptibility to leprosy or leprosy types and polymorphisms in different genes [2, [31] [32] [33] [34] [35] [36] [37] . We also found an association between certain allelic lengths of the TLR2 microsatellite and susceptibility to leprosy or leprosy type, but these were not as strong as the association with reversal reaction. This suggests that TLR2 is differentially involved in the clinical manifestation of leprosy and/or that mutations in other genes (such as TLR1 or TLR6) may have a stronger effect on susceptibility to leprosy or leprosy type.
A Turkish study revealed an association between susceptibility to tuberculosis and the TLR2 2258G3 A SNP (R753Q), which impairs TLR-2 signaling [14] . The 2258G3 A SNP was not found among Ethiopian patients with leprosy and control subjects and seems to be restricted to white populations. In contrast with the 2258G3 A SNP, the TLR2 597C3 T SNP described here does not induce an amino acid change. This SNP may be in linkage disequilibrium with another functional SNP in TLR2 or in a gene located nearby. Currently available genetic databases do not contain a TLR2 nonsynonymous SNP in linkage disequilibrium with 597C3 T, but one cannot exclude the possibility that such a polymorphism exists in certain populations. This SNP may also be in linkage disequilibrium with another SNP located in the TLR2 promoter or at the 3' end of mRNA and thereby influence promoter activity or the stability of the transcript. In the same way, different allelic lengths of the TLR2 microsatellite marker were shown to have functional consequences. A recent study indicated that length variation in the GT repeat of the TLR2 microsatellite marker influences promoter activity and suggested a possible function for this polymorphism through alteration of TLR-2 expression levels [15] . Thus, it is possible that patients homozygous for the 280-bp allelic length have stronger responses to mycobacterial products and tend to shift their adaptive response toward the Th1 pattern.
Like many genetic-association studies, our study may be affected by population stratification. To address this issue, we performed stratified analysis within each ethnic group. We found that significant associations were consistent among the 3 ethnic groups, suggesting that population stratification may not have been a major issue. As previously mentioned, another limitation results from the fact that the TLR2 SNPs (such as 597C3 T) and/or haplotypes may be in linkage disequilibrium with mutations in another gene located nearby that are responsible for the alterations in the phenotype. In addition, the fact that the multiple end points addressed in this study (susceptibility to leprosy, leprosy type, and leprosy reactions) by use of a multiallelic marker (microsatellite) involves a large number of different tests may lead to false-positive results. There is no definite consensus on which is the best method for achieving multiple-testing correction that will account for the fact that different markers within the same gene are not fully independent from each other [38] . Although the associations between different allelic lengths of the microsatellite marker and leprosy or leprosy type (which had a low level of significance) require validation in a separate study, the strength and the significance level of the association between the 280-C-T/280-C-T diplotype and reversal reaction were more suggestive of a real genetic effect. Significance would still be achieved if the Bonferroni correction were applied, assuming 100 independent tests. Furthermore, that TLR-2 is clearly involved in the innate immune response to mycobacteria, that mutations in TLR2 have been shown to be associated with susceptibility to mycobacterial diseases, and that the length of the microsatellite marker influences TLR2 expression (together with the consistency of the observation among ethnic groups) suggest that the TLR2 polymorphisms are truly responsible for the observed phenotype.
Overall, our data show that polymorphisms in genes encoding TLRs can, at least in part, explain differences in susceptibility to reversal reaction in leprosy, thereby confirming a role for TLR2 in the pathogenesis of mycobacterial infections. A larger genetic study may help to refine risk stratification by identifying haplotypes that confer high, intermediate, or low risk of reversal reaction. The present study provides new insights into the immunogenetics of leprosy.
